brain metastases

brain metastases

A generic term for cancer which has spread from a primary tumour, most commonly small cell carcinoma, of the lung to the brain.

brain metastases

Oncology Cancer that has spread from a primary tumor, most commonly, small cell carcinoma of the lung, to the brain
References in periodicals archive ?
Priscilla Brastianos, MD, Broad Institute of Harvard and MIT Genomic characterization of brain metastases reveals novel therapeutic targets Friday, November 20, 7:00 -- 8:30 am
AZD9291: pooled Phase II efficacy and safety data in pre-treated patients with non-small cell lung cancer (NSCLC) (Abstract # 3113) and analysis of patients with and without brain metastases (Abstract # 3083)
Then the effect of age on the rate of multiple concomitant metastatic sites was tested in the entire population, and according to the 5 most common metastatic sites and to brain metastases.
19, 2013 /PRNewswire/ -- Novocure announced today that the first patients have enrolled in the EF-21 Study, a prospective randomized clinical study of NovoTTF(TM) Therapy for patients with brain metastases from non-small cell lung carcinoma (NSCLC) cancer.
When Scannell was first diagnosed with brain metastases and an incurable melanoma, he was not expected to live long.
Approximately 200 000 cases of brain metastases occur in the US each year (1), and between 20% and 40% of patients with systemic cancers develop brain metastasis during the course of their disease (2).
It also created the potential to treat brain metastases, which in many cases may not require the precision provided by a very rigid frame.
On May 3, 2004, Allos announced that the FDA Oncologic Drugs Advisory Committee did not recommend approval of RSR13 as an adjunct to WBRT for the treatment of patients with brain metastases originating from breast cancer.
Focus on treating brain metastases with Leksell Gamma Knife Perfexion
Fast Track Designition were also awarded to Xcytrin for treating patients brain metastases.
In her 2010 independent study entitled, "Control of Brain Metastases in the Eloquent Brain Using Stereotactic Radiosurgery," Dr.
GRN1005 is entering two Phase 2 clinical trials this year, one for brain metastases arising from non-small cell lung cancer and the other for brain metastases from breast cancer.